Latest Insider Transactions at Azenta, Inc. (AZTA)
This section provides a real-time view of insider transactions for Azenta, Inc. (AZTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Azenta, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Azenta, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2022
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
3,778
+10.49%
|
-
|
|
Nov 17
2022
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
1,889
+18.2%
|
-
|
|
Nov 17
2022
|
Mitchell Coyne SVP and GM, Life Sciences Proj |
BUY
Grant, award, or other acquisition
|
Direct |
1,889
+50.0%
|
-
|
|
Nov 15
2022
|
Kimberly Crowley SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
574
-10.88%
|
-
|
|
Nov 15
2022
|
David C Gray Chief Strategy & New Business |
SELL
Payment of exercise price or tax liability
|
Direct |
5,235
-5.55%
|
-
|
|
Nov 15
2022
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
10,200
+9.76%
|
-
|
|
Nov 15
2022
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,535
-4.51%
|
-
|
|
Nov 15
2022
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
10,687
+9.61%
|
-
|
|
Nov 15
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,091
-8.34%
|
-
|
|
Nov 15
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,403
+14.43%
|
-
|
|
Nov 15
2022
|
Stephen S Schwartz CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,293
-6.14%
|
-
|
|
Nov 15
2022
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
48,580
+10.19%
|
-
|
|
Nov 15
2022
|
Vandana Sriram SVP Finance & Corp. Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-2.28%
|
-
|
|
Nov 15
2022
|
Robin Vacha SVP, GM Life Science Products |
SELL
Payment of exercise price or tax liability
|
Direct |
5,838
-17.02%
|
-
|
|
Nov 15
2022
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
11,077
+24.41%
|
-
|
|
Nov 15
2022
|
Ginger Zhou SVP and General Manager, Genom |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-9.34%
|
-
|
|
Nov 15
2022
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
2,236
+23.49%
|
-
|
|
Aug 19
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,350
+4.15%
|
$247,950
$57.62 P/Share
|
|
Aug 19
2022
|
Matthew Mc Manus EVP & Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
8,625
+22.64%
|
$500,250
$58.15 P/Share
|
|
Jul 29
2022
|
Linda De Jesus Chief Commercial Officer, LS |
BUY
Grant, award, or other acquisition
|
Direct |
43
+1.53%
|
$2,451
$57.49 P/Share
|
|
Jul 29
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
98
+0.1%
|
$5,586
$57.49 P/Share
|
|
Jul 29
2022
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
144
+2.66%
|
$8,208
$57.49 P/Share
|
|
Jul 29
2022
|
Vandana Sriram SVP Finance & Corp. Controller |
BUY
Grant, award, or other acquisition
|
Direct |
292
+7.6%
|
$16,644
$57.49 P/Share
|
|
Apr 12
2022
|
Kimberly Crowley SVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
132
-2.51%
|
$10,296
$78.02 P/Share
|
|
Feb 11
2022
|
Frank Casal |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+46.8%
|
-
|
|
Feb 11
2022
|
Erica Mc Laughlin |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+22.17%
|
-
|
|
Feb 11
2022
|
Krishna G. Palepu Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+1.85%
|
-
|
|
Feb 11
2022
|
Michael Rosenblatt |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+21.61%
|
-
|
|
Feb 11
2022
|
Mark S Wrighton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+1.69%
|
-
|
|
Feb 11
2022
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+3.3%
|
-
|
|
Feb 11
2022
|
Robyn C Davis |
BUY
Grant, award, or other acquisition
|
Direct |
1,922
+7.56%
|
-
|
|
Feb 11
2022
|
Joseph R Martin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,808
+3.1%
|
-
|
|
Jan 31
2022
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110
+2.05%
|
$7,590
$69.29 P/Share
|
|
Jan 31
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
189
+0.2%
|
$13,041
$69.29 P/Share
|
|
Jan 31
2022
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
285
+1.21%
|
$19,665
$69.29 P/Share
|
|
Jan 06
2022
|
Joseph R Martin Director |
SELL
Bona fide gift
|
Direct |
1,000
-1.16%
|
-
|
|
Jan 04
2022
|
Linda De Jesus Chief Commercial Officer, LS |
SELL
Open market or private sale
|
Direct |
191
-6.56%
|
$19,482
$102.59 P/Share
|
|
Nov 19
2021
|
David Jarzynka President, Semi Solutions |
SELL
Open market or private sale
|
Direct |
10,216
-18.07%
|
$1,225,920
$120.29 P/Share
|
|
Nov 18
2021
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
4,049
-4.59%
|
$477,782
$118.48 P/Share
|
|
Nov 18
2021
|
Robin Vacha SVP, GM Life Science Products |
SELL
Open market or private sale
|
Direct |
6,490
-22.06%
|
$772,310
$119.03 P/Share
|
|
Nov 17
2021
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
7,402
-3.92%
|
$880,838
$119.27 P/Share
|
|
Nov 17
2021
|
David Jarzynka President, Semi Solutions |
SELL
Open market or private sale
|
Direct |
13,100
-9.7%
|
$1,558,900
$119.27 P/Share
|
|
Nov 17
2021
|
David Pietrantoni Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,830
-7.68%
|
$574,770
$119.27 P/Share
|
|
Nov 17
2021
|
Lindon G Robertson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,331
-8.27%
|
$2,181,389
$119.27 P/Share
|
|
Nov 17
2021
|
Stephen S Schwartz CEO |
SELL
Open market or private sale
|
Direct |
41,351
-4.99%
|
$4,920,769
$119.27 P/Share
|
|
Nov 17
2021
|
Robin Vacha SVP, GM Life Science Products |
SELL
Open market or private sale
|
Direct |
8,878
-12.07%
|
$1,056,482
$119.27 P/Share
|
|
Nov 17
2021
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
8,694
-4.47%
|
$1,034,586
$119.27 P/Share
|
|
Nov 15
2021
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,092
+17.48%
|
-
|
|
Nov 15
2021
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
18,292
+8.33%
|
-
|
|
Nov 15
2021
|
David Jarzynka President, Semi Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
25,710
+26.97%
|
-
|